Subcutaneous omalizumab for people with asthma

Overview of attention for article published in Cochrane database of systematic reviews, July 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

news: 1 news outlet
twitter: 4 X users

facebook: 1 Facebook page

Readers on

mendeley: 12 Mendeley

Summary News X Facebook

So far, Altmetric has seen 1 news story.

Subcutaneous omalizumab for people with asthma

Cochrane, 22 Jul 2021

Donovan T, Milan SJ, Adatia A, Solkar Z, Stovold E, Dwan K, Hinks TSC, Crossingham I.